Physician profile
Rani Patil
NPI 1861812117
$408.88
in general payments reported to CMS, 2019-2025
13 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.68 · 2022: $19.59 · 2023: $106 · 2024: $95.69 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $93.24 | 2023-2025 | |
| Pfizer INC. | $54.72 | 2023-2025 | |
| Phadia US INC. | $37.56 | 2025 | Immunocap |
| Boston Scientific Corporation | $33.75 | 2025 | Wavewriter Alpha Prime 16 |
| Amgen INC. | $30.98 | 2023-2025 | Repatha, Repatha, Otezla |
| Astrazeneca Pharmaceuticals Lp | $28.64 | 2023-2024 | Farxiga, Airsupra |
| Corium, LLC | $23.16 | 2025 | Azstarys |
| Medtronic, INC. | $21.64 | 2024 | Intellis Adaptivestim |
| Novo Nordisk INC | $21.38 | 2021 | |
| Lilly USA, LLC | $19.59 | 2022 | |
| Astellas Pharma US INC | $17.46 | 2023 | Veozah |
| Exact Sciences Corporation | $13.46 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $13.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rani Patil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.